Breast Tumor Resembling the Tall Cell Variant of Papillary Thyroid Carcinoma: Report of 4 Cases With Evidence of Malignant Potential

Abstract

A new type of breast carcinoma resembling the tall cell variant of papillary thyroid carcinoma has recently been described. To date, rare cases are on record. Here, 4 new cases of the tall cell variant of papillary thyroid carcinoma of the breast are described in women aged from 45 to 80 years old. All patients presented with palpable breast nodules and were treated with quadrantectomy. One patient presented with a long clinical history and a metastatic intramammary lymph node. The patient is alive and well 3 months after surgery. The remaining 3 patients are disease free at mean 7.5 months (range, 5 to 10 months) after surgery. These data suggest that papillary thyroid-like carcinomas of the breast show malignant potential.

Keywords

breast carcinoma papillary carcinoma thyroid mitochondria

Get full access to this article

View all access options for this article.

References

Fattaneh A , Tavassoli FA , Devilee P (eds). WHO Tumours of the Breast and Female Genital Organs. Lyon, France: IARC; 2003.

Eusebi V , Damiani S , Ellis IO , Azzopardi JG , Rosai J. Breast tumour resembling the tall cell variant of papillary thyroid carcinoma: report of 5 cases. Am J Surg Pathol. 2003;27: 1114-1118.

Eusebi V , Tallini G , Rosai J. Nuclear alterations and RET/PTC activation. Am J Surg Pathol. 2004;28: 974-975.

Camaselle-Teijeiro J , Abdulkader I , Barreiro-Morandeira F , et al. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: a case report. Int J Surg Pathol. 2006;14: 79-84.

DeLellis RA , Lloyd RV , Heitz PU , Eng C (eds). WHO Tumors of Endocrine Organs. Lyon, France: IARC; 2004.

Papotti M , Manazza AD , Chiarle R , Bussolati G. Confocal microscope analysis and tridimensional reconstruction of papillary thyroid carcinoma nuclei. Arch Vir. 2004;444: 350-355.

Fiche M , Cassagnau E , Aillet G , et al. Breast metastasis from a “tall cell variant” of papillary thyroid carcinoma. Ann Pathol. 1998;18: 130-132.

Lau SK , Luthringer DJ , Eisen RN. Thyroid transcription factor-1: a review. Appl Immunol Mol Mor. 2002;10: 97-102.

Pagani A , Sapino A , Eusebi V , Bergnolo P. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Arch. 1994;5: 459-465.

10.

Wick MR , Lillemore TJ , Copland GT , Swanson PE , Manivel JC , Kiang DT. Gross cystic fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol. 1989;20: 281-287.

11.

Mazoujian G , Pinkus GS , Davis S , Haagensen DE Jr. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas. Am J Pathol. 1983; 110: 105-111.

12.

Kuijpens JLP , Nyklictek I , Louwman MWJ , Weetman TAP , Pop VJM , Coebergh JWW. Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid. 2005;15: 1253-1259.

13.

Choe GS , Kim YR , Kim KN , et al. Altered gene expression profiles by sodium/iodide symporter gene transfection in a human anaplastic thyroid carcinoma cell line using a radioactive complementary DNA microarray. Nucl Med Commun. 2005;26: 1155-1162.